EP0593421A4 - Biodegradable superabsorbing sponge. - Google Patents
Biodegradable superabsorbing sponge.Info
- Publication number
- EP0593421A4 EP0593421A4 EP19900905032 EP90905032A EP0593421A4 EP 0593421 A4 EP0593421 A4 EP 0593421A4 EP 19900905032 EP19900905032 EP 19900905032 EP 90905032 A EP90905032 A EP 90905032A EP 0593421 A4 EP0593421 A4 EP 0593421A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- cross
- linking agent
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/15203—Properties of the article, e.g. stiffness or absorbency
- A61F13/15252—Properties of the article, e.g. stiffness or absorbency compostable or biodegradable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F2013/530481—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
- A61F2013/530583—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the form
- A61F2013/530649—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the form in sponge or foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F2013/530481—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
- A61F2013/530795—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials being biodegradable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F13/534—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having an inhomogeneous composition through the thickness of the pad
- A61F2013/53481—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having an inhomogeneous composition through the thickness of the pad being biodegradable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
- A61F2013/8438—Additives, e.g. for odour, disinfectant or pH control being enzymes, e.g. proteolysis, cellulase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
- A61F2013/8447—Additives, e.g. for odour, disinfectant or pH control in using different incompatible substances
- A61F2013/8452—Additives, e.g. for odour, disinfectant or pH control in using different incompatible substances being contained in microcapsules
Definitions
- the present invention relates to biodegradable gels which act as superabsorbing sponges. More particularly, the gel of the invention has as high, or higher, liquid and saline uptake than the polyacrylate superabsorbers now being used while having the advantage of being completely biodegradable.
- the first major improvement in the disposable diaper field was the addition of the so-called "superabsorbers” as liquid traps.
- These superabsorbers are primarily polyacrylate particles which are placed in the diaper in loose form or are entrapped among cellulose fibers. These polyacrylate particles absorb large quantities of water by swelling and acting as individual pseudo-sponges. Since the amount of saline and urine which can be absorbed by these superabsorbers is so much greater than cellulose or other natural fibers, very thin diapers could be used, minimizing the problems to infants and making disposables the diaper of choice.
- the polyacrylate gel beads move freely relative to each other and form large spaces between each other. However, once fully hydrated, these polyacrylate superabsorbers tend to clump, causing a lumpy diaper and discomfort to the infant.
- the superabsorbers In addition to the use in diapers, the superabsorbers have other uses. Many other items which are used for absorption of liquid are a fertile ground for use of the superabsorbers.
- the polyacrylate superabsorbers have one major disadvantage; they are not biodegradable. This means that the diapers and all other products made using these superabsorbers are not degraded for decades; in fact, they need hundreds of years to breakdown. This leads to the aforementioned waste problem.
- Another disadvantage of the polyacrylates is that they absorb maximally at 0% saline while urine and most body fluids are about 0.15 N saline.
- Materials which absorb liquid and are biodegradable such as those of the present invention have other possible uses as well.
- Superabsorbers have not made a great dent in this field even though they have the necessary liquid absorption because they cannot entrap large particulates.
- a biodegradable material which will entrap liquid and/or particles is as a sustained release vehicle.
- the molecules to be delivered can be part of the structural material of the sponge itself.
- a further use of a gel which entraps liquids and particles is as a biological protective barrier.
- a gel which entraps bacteria as it is hydrated, or prevents their passage once formed can be used as a wound dressing, protecting the wound from bacteria while allowing air flow and/or free flow of liquid to the injury.
- a further use is in a diaper where coliform bacteria can breakdown urea in urine to ammonia, changing the pH and promoting diaper rash.
- an object of the invention is to provide a biodegradable material that has high uptake for water and saline.
- Another object of the invention is to provide a biodegradable carrier or sustained release delivery system for drugs and other molecules.
- a further object of the invention is to provide a material and method for entrapment of particulates such as erythrocytes and protein molecules such as hemoglobin.
- a still further object of the invention is to provide a protective barrier which prevents the passage of particles such as bacteria or macromolecules, e.g., for use as a wound bandage.
- the present invention features a composition of matter which acts as a synthetic sponge as well as methods of absorbing aqueous or saline solutions.
- the invention further features methods of entrapping particles in a gel.
- the gel-like composition of matter can be used as a protective barrier and as a sustained release vehicle which releases entrapped particles or molecules such as drugs over time.
- composition of matter which acts as a synthetic sponge when allowed to hydrate.
- a high molecular weight, complex carbohydrate with multiple anion-ter inated branches and a cross-linking agent are blended under substantially anhydrous conditions, preferably with a carboxylic acid with a substantial hydrophobic region.
- Preferred carboxylic acids with substantial hydrophobic regions are fatty acids selected from a group consisting of lauric acid, palmitic acid, oleic acid, stearic acid, benzoic acid, or mixtures thereof.
- a substantial hydrophobic region means and implies a region with a substantial hydrocarbon chain or ring structure.
- Preferred branch complex carbohydrates include carboxymethylcellulose, and chemical analogues thereof. Linear complex carbohydrates such as cellulose, gum xanthan, gum karaya, or alginic acid may also be included.
- the components of the mixture can be hydrated and cross-linked substantially simultaneously when in the presence of the hydrating solution.
- Any of the components may be premixed together or impregnated with one another.
- the other reactants may be derivatized with the complex or linear carbohydrates using an isopropoxide or other similar reaction.
- Some or all of the fatty acid can be replaced with a "functional fatty acid” or a long-chain carboxylic acid.
- the term "functional fatty acid” means, includes and defines a molecule having a terminal carboxylic acid, a substantial aliphatic portion, and a biological function other than as a breakdown product or precursor in the food chain.
- Functional fatty acids include acids such as undecylenic acid, arachidonic acid, prostaglandins, prostacyclins, thromboxanes, and their derivatives, chemical analogues and precursors.
- composition of matter of the invention includes a cross-linking agent as an essential component.
- the preferred cross-linking agents are metallo-organic compounds of multivalent metals.
- Organic cross-linking agents such as chitosan, Poly-Cup, chymene, and jeffamine may be used, but are less efficient than the metallo-organic complexes.
- Oxytetracyline is a highly effective cross-linking agent but has limited application because of its biological activity.
- bivalent molecules such as calcium might be used in certain circumstances, the multivalent metals (valence 3 and over) such as aluminum or chromium are preferred.
- a most preferred cross-linking agent providing superior performance is an aluminum metallo-organic complex of the hydroxy-aluminum/hydrophobic carboxylate form such as hydroxy-aluminum benzoate.
- This agent can act as both the hydrophobic carboxylic acid and the cross-linking agent in a single molecule.
- Other hydrophobic carboxylic acids such as laurate, stearate, oleate or benzoate can also be used in the metallo-organic complex.
- the invention further features a method of absorbing aqueous or saline solutions using the biodegradable synthetic sponge composition of the invention.
- the synthetic sponge composition is provided in a substantially unhydrated form, for example, by blending the components together to obtain particles of the desired size, and then the solution is absorbed by contacting the solution with the synthetic sponge composition.
- the synthetic sponge composition hydrates to absorb the solution and substantially simultaneously cross-links into a gel which binds the solution.
- the same basic material may be used to encapsulate particles in a gel.
- the synthetic sponge composition is provided in a substantially unhydrated form and a solution containing the particles to be entrapped within the gel is mixed with the composition.
- the gel forms by cross-linking, absorbing the liquid and entrapping the particles within the gel.
- Particles which can be entrapped in this way include macromolecules or proteins such hemoglobin, bacteria, or cells such as erythrocytes.
- gels cross-linked by oxytetracycline can be used as a sustained release vehicle for this drug.
- Many positively charged drugs can be held in polyanionic gels for sustained release.
- the stability, absorption levels, and firmness of the gel can be modified.
- changing the fatty acid/carbohydrate ratio can dramatically change the absorption, and the subsequent release rate, of liquid from the gel.
- the addition of other materials to the gel e.g., surfactants such as polyoxyethylene fatty acid ethers or spacers such as silica or clays, can change the properties of the gel. This change of properties is more clearly explained in the description and the Examples.
- the hydrated gel described herein is formed by the simultaneous hydration and cross-linking by a cross-linking agent of polyanionic carbohydrates, preferably together with hydrophobic carboxylates.
- a cross-linking agent of polyanionic carbohydrates preferably together with hydrophobic carboxylates.
- the material of the present invention exists in uncross-linked form prior to hydration.
- the material forms extend, water-binding networks of biodegradable carbohydrate polymer, preferably further cross-linked with extended multilamellar sheets of degradable, anionic lipid.
- the gels are stable and can extend several centimeters in several directions upon hydration.
- gels can also be formed into a variety of geometries such as rods, disks, and slabs.
- the consistency of the gel, and the amount of liquid absorbed, can be changed by modifying the initial composition.
- a partially hydrated gel can be further hydrated at a later time by absorption of more liquid.
- the capacity for uptake of liquid of the compositions of the present invention furthermore depends on the ratio of active acid, e.g., lipids, to active carbohydrate.
- active acid e.g., lipids
- active carbohydrate e.g., lipid/carbohydrate ratios (on a weight basis), e.g., a 0.1 - 0.2 ratio
- high fluid absorption is observed.
- the uptake of 0.15 N saline is considerably greater than that of the polyacrylate superabsorbers.
- the ratio of fatty acid to carbohydrate is much higher, e.g., approximately 1, the gels do not absorb as much liquid, give up the liquid easier, and act as better delivery systems.
- Functional fatty acids can be used to replace some or all of the fatty acid.
- the major advantage of using these functional fatty acids is that as the gels are degraded, the functional fatty acid is released. This acts as a type of delivery system which can have a much higher concentration of the material to be delivered than could be possible in another type of encapsulation or entrapment system. In fact, a certain proportion of the fatty acid can be replaced by any carboxyl terminated molecule.
- linear carbohydrates such as cellulose.
- Other linear carbohydrates which have been shown to be effective include carbohydrates with terminal glucoronic acid such as alginic acid, gum xanthan and gum karaya. Non-cross-linkable soluble carboxylic acids do not appear to work.
- This Example shows the fluid uptake of saline for a composition of the invention with low lipid/carbohydrate ratio under pressure conditions designed for testing polyacrylate superabsorbers.
- Approximately 0.05 g (0.2 mmol) of palmitic acid was blended with 0.5 g carboxymethylcellulose and 0.02 g (0.14 mmol) borate-stabilized dihydroxy aluminum- acetate and 1.5 g of cellulose fiber. Blending took place at room temperature by mixing the materials together until they were uniformly blended. The materials were then milled into 500 micron particles.
- a high lipid/carbohydrate material was made and tested under the same conditions.
- This high ratio material is made by blending 1 g of palmitic acid with 1 g of carboxymethylcellulose and 0.04 g of the borate-stabilized dihydroxy aluminum acetate complex. Small portions of the sample (approximately 0.1 g) were blended with 0.5 g of cellulose fiber.
- the two samples were tested under the same procedure, as was a polyacrylate superabsorber.
- the test procedure hydrated the materials by capillary action with 0.15 M NaCl under applied load of 0.22 lbs./in 2 for sixty minutes at room temperature.
- the amount of fluid take up was then determined gravimetrically.
- the data shown in all the Tables of Examples show the amount of fluid uptake for the synthetic sponge, determined by correcting for the amount of fluid taken up by the cellulose alone which was determined separately.
- Table 1 shows that the fluid uptake for the low lipid/carbohydrate ratio, in ml of liquid/g of absorber, is higher than the superabsorber while a lower amount, but still significant, is absorbed by the high lipid/carbohydrate ratio material. This shows that a simple modification of ratios, using exactly the same materials, can lead to a control in the amount of liquid taken up by the gel.
- the first gel a low lipid/carbohydrate ratio gel, was made by blending 0.05 g palmitic acid with 0.5 g carboxymethylcellulose and 0.02 g of the borate-stabilized dihydroxy aluminum acetate complex. Approximately 0.3 g of this mixture was then blended with 1.5 g of cellulose fiber.
- the second gel of the invention was made by blending 1.0 g of palmitic acid with 1.0 g of carboxymethylcellulose and 0.04 g of the borate-stabilized dihydroxy aluminum acetate complex. Again, 0.3 g of this mixture was blended with 0.5 g of cellulose fiber.
- the low lipid/carbohydrate ratio material had a greater fluid retention than the superabsorber while the high lipid/carbohydrate ratio material had a lower retention.
- Example 3 the same high lipid/carbohydrate ratio gel as used in Example 3 was used to show the effects of isotonic changes and permeability of small particles.
- the gel was -manufactured as described above and was hydrated with 25 ml of plain water. The gel was then soaked alternately in several changes of 0.5 ml of 1 M sucrose then water.
- the gels would also be permeable to molecules of approximately the same size as sucrose including many drugs. Accordingly, the gels could be used as a wound bandage which allows passage of a drug through the gel to where it is necessary but protection against large particulate-type matter such as bacterial cells.
- exposure of gels to a 20% solution of high molecular weight dextran (140,000 Mol. Wt.) causes reversible shrinking, suggesting that these molecules do not penetrate the gels and cause osmotic loss of water from the gels.
- a functional fatty acid is used in place of a standard fatty acid in forming the gel of the invention.
- This functional fatty acid is a potent fungicide.
- the soft gel is slightly turbid, spreads easily, and sticks to the skin. Because of this., a bandage or wound covering of the undecylenic acid gel could be applied to the skin, providing fungicidal benefits as well as protection against particulate bacteria and infection.
- Example 6
- a palmitate-based aluminum metallo-organic complex (PX-L) is made by mixing 0.64 g palmitic acid (0.25 mmol) dissolved in 5 ml of ethanol with 1.4 g (10 mmol) aluminum monoacetate stabilized with boric acid in 5 ml of water.
- An opalescent solution resulted.
- This opalescent suspension can be mixed with carboxymethylcellulose (CMC), with or without cellulose fiber, to provide a cross-linking agent impregnated in the CMC. This same procedure may be used with equal molar amounts of lauric or stearic acid to form similar complexes.
- CMC carboxymethylcellulose
- BX-L aluminum metallo-organic complex
- a more dilute solution is used. Specifically, 0.61 g of benzoic acid (0.50 mmol) was dissolved in 7.5 ml of ethanol. The benzoic acid solution was mixed with a solution containing 1.4 g (10 mmol) aluminum monoacetate stabilized with boric acid in 7.5 ml of water. Again, an opalescent suspension resulted.
- This cross-linking agent can also be impregnated into or derivatized with CMC or cellulose fiber.
- Example 6 the organo-metallic cross-linking agents formed in Example 6 were used to form the sponge-like material of the invention.
- CMC carboxymethylcellulose
- PA palmitic acid
- BX-L benzoate-based aluminum metallo-organic cross-linking agent
- the mixture was hydrated by thirty seconds of magnetic stirring and the still-liquid mixture was transferred to 50 ml centrifuge tubes and centrifuged at 300 X g for thirty minutes. At the end of the thirty minute centrifuge period, any free fluid was collected by filtration through a 150 ⁇ pore size nylon mesh. Highly cohesive, firm gels form within the thirty minute centrifugation.
- composition of the invention clearly is superior to the polyacrylic superabsorbers in terms of retention of 0.15 N saline.
- Example 6 a 20% whole blood solution was tested for absorption by a composition of the invention made with the benzoate-based cross-linking agent (BX-L) of Example 6.
- the composition was made by mixing 0.2 g of carboxymethylcellulose, 0.04 g of palmitic acid, 50 ml of 20% whole blood, 0.15 N saline and 1 ml of the cross-linking agent. Again, the material was tested with and without 0.6 g of cellulose. After hydration, the still-liquid mix was divided into to two 25 ml portions, these were transferred to 50 ml centrifuge tubes, and gelation was allowed to proceed under centrifugation at 300 X g (average 4800 lbs./in 2 ) for thirty minutes.
- BX-L benzoate-based cross-linking agent
- undecylenic acid is incorporated into a gel containing the benzoate-based aluminum metallo-organic complex of Example 6.
- Approximately 0.5 ml of the cross-linking complex was combined with 0.5 ml carboxymethylcellulose and 0.5 g of undecylenic acid.
- the material was hydrated with 70 ml with deionized water.
- a high cohesive but mobile gel formed within thirty minutes. There was no release of water over a period of more than three hours and there was no separation of free undecylenic acid.
- carboxyl terminal functional molecules such as prostaglandins, prostacyclins, thromboxanes and their precursors such as arachidonic acid.
- certain antibiotics such as oxytetracyline can be used in place of some or all of the cross-linking agents.
- fatty acid examples include carboxylic acids, carboxylic peptides, nonionic surfactants, and steroids such as cholesterol or hydrocortisone. Selection of proper acidic constituents can modify gel properties.
- the steroid can be present in the system up to at least 10% of the fatty acid without disturbing the gel. Therefore, these gels could be used as a delivery systems for a variety of molecules such as steroids.
- lipid vesicles can be incorporated into the gels as particulate matter. Since these lipid vesicles can also be designed to carry a variety of materials which could not otherwise be carried in the gel, a wound patch or other covering made of the gel with the vesicles dispersed therein could be used to apply drugs on a time-released basis to a selected site.
Abstract
A new superabsorber which gels and cross-links as hydrated has been developed. The superabsorber contains a branched-chain polyanionic carbohydrate such as carboxymethylcellulose, a cross-linking agent, and a hydrophobic carboxylic acid. The superabsorber is biodegradable and non-toxic.
Description
BIODEGRADABLE SUPERABSORBING SPONGE
Background of the Invention
The present invention relates to biodegradable gels which act as superabsorbing sponges. More particularly, the gel of the invention has as high, or higher, liquid and saline uptake than the polyacrylate superabsorbers now being used while having the advantage of being completely biodegradable.
Biodegradability has become a necessity in society in the last few years. As more and more products are made disposable, the waste problems associated with these disposables have become increasingly important. One example of this is the disposable diaper field. Until a few years ago, disposable diapers, though convenient, had not received widespread use because the amount of liquid which could be absorbed was limited. This limitation lead to use of the diapers for extraordinary circumstances but they were not feasible for most people on a day-to-day basis because of the leakage and resulting diaper rash problem. In order to solve these problems, the diaper manufacturers first used very thick diapers, placing large amounts of fiber such as cellulose in the diaper to act as a liquid, primarily saline and urine, absorber. These bulky diapers still had limitations on the amount of
liquids they could retain while the bulk made them uncomfortable for the infants to wear.
The first major improvement in the disposable diaper field was the addition of the so-called "superabsorbers" as liquid traps. These superabsorbers are primarily polyacrylate particles which are placed in the diaper in loose form or are entrapped among cellulose fibers. These polyacrylate particles absorb large quantities of water by swelling and acting as individual pseudo-sponges. Since the amount of saline and urine which can be absorbed by these superabsorbers is so much greater than cellulose or other natural fibers, very thin diapers could be used, minimizing the problems to infants and making disposables the diaper of choice. The polyacrylate gel beads move freely relative to each other and form large spaces between each other. However, once fully hydrated, these polyacrylate superabsorbers tend to clump, causing a lumpy diaper and discomfort to the infant.
In addition to the use in diapers, the superabsorbers have other uses. Many other items which are used for absorption of liquid are a fertile ground for use of the superabsorbers. However, the polyacrylate superabsorbers have one major disadvantage; they are not biodegradable. This means that the diapers and all other products made using these superabsorbers are not degraded for decades; in fact, they need hundreds of years to breakdown. This leads to the aforementioned waste problem. Another disadvantage of the polyacrylates is that they absorb
maximally at 0% saline while urine and most body fluids are about 0.15 N saline.
Materials which absorb liquid and are biodegradable such as those of the present invention have other possible uses as well. The entrapment of particles, including acromolecules such as hemoglobin and cells such as erythrocytes, is particularly important for feminine napkins and similar products. Superabsorbers have not made a great dent in this field even though they have the necessary liquid absorption because they cannot entrap large particulates.
Another possible use for a biodegradable material which will entrap liquid and/or particles is as a sustained release vehicle. In certain instances, the molecules to be delivered can be part of the structural material of the sponge itself. Most materials which are presently being tested as sustained release vehicles, e.g., microcapsules, liposomes and related capsular type products, have substantial costs and time associated with their manufacture. The ability to make a product An. situ. apply it to a given area, and then let it degrade under ordinary conditions to release entrapped material, would solve many problems.
A further use of a gel which entraps liquids and particles is as a biological protective barrier. For example, a gel which entraps bacteria as it is hydrated, or prevents their passage once formed, can be used as a wound dressing, protecting the wound
from bacteria while allowing air flow and/or free flow of liquid to the injury. A further use is in a diaper where coliform bacteria can breakdown urea in urine to ammonia, changing the pH and promoting diaper rash.
Accordingly, an object of the invention is to provide a biodegradable material that has high uptake for water and saline.
Another object of the invention is to provide a biodegradable carrier or sustained release delivery system for drugs and other molecules.
A further object of the invention is to provide a material and method for entrapment of particulates such as erythrocytes and protein molecules such as hemoglobin.
A still further object of the invention is to provide a protective barrier which prevents the passage of particles such as bacteria or macromolecules, e.g., for use as a wound bandage.
These and other objects and features of the invention will be apparent from the following description.
Summary of the Invention
The present invention features a composition of matter which acts as a synthetic sponge as well as methods of absorbing aqueous or saline solutions.
The invention further features methods of entrapping particles in a gel. The gel-like composition of matter can be used as a protective barrier and as a sustained release vehicle which releases entrapped particles or molecules such as drugs over time.
In brief, a composition of matter has been developed which acts as a synthetic sponge when allowed to hydrate. A high molecular weight, complex carbohydrate with multiple anion-ter inated branches and a cross-linking agent are blended under substantially anhydrous conditions, preferably with a carboxylic acid with a substantial hydrophobic region. Preferred carboxylic acids with substantial hydrophobic regions are fatty acids selected from a group consisting of lauric acid, palmitic acid, oleic acid, stearic acid, benzoic acid, or mixtures thereof. A substantial hydrophobic region means and implies a region with a substantial hydrocarbon chain or ring structure. Preferred branch complex carbohydrates include carboxymethylcellulose, and chemical analogues thereof. Linear complex carbohydrates such as cellulose, gum xanthan, gum karaya, or alginic acid may also be included.
Once the components are intimately blended, e.g., milled together, the components of the mixture can be hydrated and cross-linked substantially simultaneously when in the presence of the hydrating solution. Any of the components may be premixed together or impregnated with one another. In addition, the other reactants may be derivatized with the complex or linear carbohydrates using an
isopropoxide or other similar reaction. Some or all of the fatty acid can be replaced with a "functional fatty acid" or a long-chain carboxylic acid. As used herein, the term "functional fatty acid" means, includes and defines a molecule having a terminal carboxylic acid, a substantial aliphatic portion, and a biological function other than as a breakdown product or precursor in the food chain. Functional fatty acids include acids such as undecylenic acid, arachidonic acid, prostaglandins, prostacyclins, thromboxanes, and their derivatives, chemical analogues and precursors.
As noted, the composition of matter of the invention includes a cross-linking agent as an essential component. The preferred cross-linking agents are metallo-organic compounds of multivalent metals. Organic cross-linking agents such as chitosan, Poly-Cup, chymene, and jeffamine may be used, but are less efficient than the metallo-organic complexes. Oxytetracyline is a highly effective cross-linking agent but has limited application because of its biological activity. Although bivalent molecules such as calcium might be used in certain circumstances, the multivalent metals (valence 3 and over) such as aluminum or chromium are preferred. For many applications aluminum in the form of hydroxy-aluminum diacetate, borate-stabilized dihydroxy-aluminum acetate and/or aluminum sulfate/citrate, may be satisfactory. A most preferred cross-linking agent providing superior performance is an aluminum metallo-organic complex of the hydroxy-aluminum/hydrophobic carboxylate form
such as hydroxy-aluminum benzoate. This agent can act as both the hydrophobic carboxylic acid and the cross-linking agent in a single molecule. Other hydrophobic carboxylic acids such as laurate, stearate, oleate or benzoate can also be used in the metallo-organic complex.
The invention further features a method of absorbing aqueous or saline solutions using the biodegradable synthetic sponge composition of the invention. The synthetic sponge composition is provided in a substantially unhydrated form, for example, by blending the components together to obtain particles of the desired size, and then the solution is absorbed by contacting the solution with the synthetic sponge composition. The synthetic sponge composition hydrates to absorb the solution and substantially simultaneously cross-links into a gel which binds the solution.
The same basic material may be used to encapsulate particles in a gel. The synthetic sponge composition is provided in a substantially unhydrated form and a solution containing the particles to be entrapped within the gel is mixed with the composition. The gel forms by cross-linking, absorbing the liquid and entrapping the particles within the gel. Particles which can be entrapped in this way include macromolecules or proteins such hemoglobin, bacteria, or cells such as erythrocytes.
Substantially the same entrapment procedure can be used to create a sustained release vehicle.
— Q 0 —
For example, gels cross-linked by oxytetracycline can be used as a sustained release vehicle for this drug. Many positively charged drugs can be held in polyanionic gels for sustained release. By modifying the ratios of the different components, and selecting the specific materials which make up the gel, the stability, absorption levels, and firmness of the gel can be modified. For example, changing the fatty acid/carbohydrate ratio can dramatically change the absorption, and the subsequent release rate, of liquid from the gel. Further, the addition of other materials to the gel, e.g., surfactants such as polyoxyethylene fatty acid ethers or spacers such as silica or clays, can change the properties of the gel. This change of properties is more clearly explained in the description and the Examples.
Detailed Description of the Invention
The hydrated gel described herein is formed by the simultaneous hydration and cross-linking by a cross-linking agent of polyanionic carbohydrates, preferably together with hydrophobic carboxylates. In contrast to the polyacrylate superabsorbers, which necessarily form discrete particles (as do covalently cross-linked molecules such as cross-linked carboxymethylcellulose, gelatins, and alginates), the material of the present invention exists in uncross-linked form prior to hydration. Upon hydration, the material forms extend, water-binding networks of biodegradable carbohydrate polymer, preferably further cross-linked with extended multilamellar sheets of degradable, anionic lipid.
Macroscopically, the gels are stable and can extend several centimeters in several directions upon hydration. These gels can also be formed into a variety of geometries such as rods, disks, and slabs. The consistency of the gel, and the amount of liquid absorbed, can be changed by modifying the initial composition. In addition, a partially hydrated gel can be further hydrated at a later time by absorption of more liquid.
The capacity for uptake of liquid of the compositions of the present invention furthermore depends on the ratio of active acid, e.g., lipids, to active carbohydrate. At low lipid/carbohydrate ratios (on a weight basis), e.g., a 0.1 - 0.2 ratio, high fluid absorption is observed. In fact, as may be seen from the following Examples, the uptake of 0.15 N saline is considerably greater than that of the polyacrylate superabsorbers. When the ratio of fatty acid to carbohydrate is much higher, e.g., approximately 1, the gels do not absorb as much liquid, give up the liquid easier, and act as better delivery systems.
Functional fatty acids can be used to replace some or all of the fatty acid. The major advantage of using these functional fatty acids is that as the gels are degraded, the functional fatty acid is released. This acts as a type of delivery system which can have a much higher concentration of the material to be delivered than could be possible in another type of encapsulation or entrapment system. In fact, a certain proportion of the fatty
acid can be replaced by any carboxyl terminated molecule.
Although branched complex carbohydrates are necessary for practice of the invention, some of these branched carbohydrate fractions can be replaced by linear carbohydrates such as cellulose. The addition of these linear carbohydrates appears to improve the absorption capability of the system, acting synergistically with the other components. Other linear carbohydrates which have been shown to be effective include carbohydrates with terminal glucoronic acid such as alginic acid, gum xanthan and gum karaya. Non-cross-linkable soluble carboxylic acids do not appear to work.
The following Examples will more clearly explain the procedures and processes of the present invention.
Example 1.
This Example shows the fluid uptake of saline for a composition of the invention with low lipid/carbohydrate ratio under pressure conditions designed for testing polyacrylate superabsorbers. Approximately 0.05 g (0.2 mmol) of palmitic acid was blended with 0.5 g carboxymethylcellulose and 0.02 g (0.14 mmol) borate-stabilized dihydroxy aluminum- acetate and 1.5 g of cellulose fiber. Blending took place at room temperature by mixing the materials together until they were uniformly blended. The materials were then milled into 500 micron particles.
In a parallel experiment, a high lipid/carbohydrate material was made and tested under the same conditions. This high ratio material is made by blending 1 g of palmitic acid with 1 g of carboxymethylcellulose and 0.04 g of the borate-stabilized dihydroxy aluminum acetate complex. Small portions of the sample (approximately 0.1 g) were blended with 0.5 g of cellulose fiber.
The two samples were tested under the same procedure, as was a polyacrylate superabsorber. The test procedure hydrated the materials by capillary action with 0.15 M NaCl under applied load of 0.22 lbs./in2 for sixty minutes at room temperature. The amount of fluid take up was then determined gravimetrically. The data shown in all the Tables of Examples show the amount of fluid uptake for the synthetic sponge, determined by correcting for the amount of fluid taken up by the cellulose alone which was determined separately.
TABLE; i
System Fluid Uptake (ml/σ)
Low Lipid/Carbohydrate 37.3
High Lipid/Carbohydrate 21.1
Superabsorber 30.4
Table 1 shows that the fluid uptake for the low lipid/carbohydrate ratio, in ml of liquid/g of absorber, is higher than the superabsorber while a
lower amount, but still significant, is absorbed by the high lipid/carbohydrate ratio material. This shows that a simple modification of ratios, using exactly the same materials, can lead to a control in the amount of liquid taken up by the gel.
Example 2.
In this Example, a different test was used to determine fluid retention by two different gels of the invention and a polyacrylate superabsorber. The first gel, a low lipid/carbohydrate ratio gel, was made by blending 0.05 g palmitic acid with 0.5 g carboxymethylcellulose and 0.02 g of the borate-stabilized dihydroxy aluminum acetate complex. Approximately 0.3 g of this mixture was then blended with 1.5 g of cellulose fiber.
The second gel of the invention was made by blending 1.0 g of palmitic acid with 1.0 g of carboxymethylcellulose and 0.04 g of the borate-stabilized dihydroxy aluminum acetate complex. Again, 0.3 g of this mixture was blended with 0.5 g of cellulose fiber.
Samples of each of the two compositions of the invention and a superabsorber (0.3 g each) were sealed in tea bags and immersed in 0.15 N saline for thirty minutes at room temperature. After removal from the saline, the tea bags were centrifuged at 300 X g for thirty minutes and the amount of saline retained within the material was determined gravimetrically. Again, there was a correction made
for the excess cellulose. Table 2 shows the results of this testing.
TABLE 2
System Fluid Retention (ml/o)
Low Lipid/Carbohydrate 43.0
High Lipid/Carbohydrate 21.1
Superabsorber 36.5
As is clear, the low lipid/carbohydrate ratio material had a greater fluid retention than the superabsorber while the high lipid/carbohydrate ratio material had a lower retention.
Example 3.
In this series of experiments, the retention of particulate material by the gels of the invention were tested. In each experiment, 1.0 g of palmitic acid was uniformly blended with 1.0 g of carboxymethylcellulose and 0.04 g of the borate-stabilized dihydroxy aluminum acetate complex, making a high ratio gel. About 0.5 g of the mixture was hydrated with 25 ml of the test suspension. In the first test, the hydration material was a suspension of human red cells in 0.15 N saline. The gelation occurred within thirty minutes. After two hours, the resulting gel was centrifugally washed with five volumes of 20% dextran (140,000 Mol. Wt.) dissolved in 0.15 N saline. Each wash had the sample centrifuged for thirty minutes at 3,000 rpm in a
Beckman centrifuge. The red cell-containing gel contracted and floated to the top half of the centrifuge tube while there was substantially no release of red cells. If the cells had been free, they would pellet at the bottom of the centrifuge tube. This shows the retention of the particulate matter, in particular erythrocytes, by the gel of the invention. Over 99% of the cells were contained within the gel, as determined spectrophotometrically. This was true for red cell suspension of 2.5-12.5 times the mixture amount used. In a similar experiment with heparin-treated whole blood, the gel was able to absorb 20 times its weight with similar retention characteristics.
Similar experiments were carried out replacing the red cell suspension with a solution of human hemoglobin in normal saline. Gelation lead to complete incorporation of the hemoglobin solution. After standing for two days, the gel was centrifugally washed five times at the 3,000 rpm for thirty minutes in the Beckman centrifuge in a dextran gradient. Only traces of hemoglobin were observed released into the dextran barrier while substantially all of the rest of the hemoglobin was retained within the gel. By spectrophotographics measurement, about 88% of the hemoglobin was retained.
A further experiment was carried out using the same procedure but replacing the red cell suspension with a suspension of paucilamellar lipid vesicles, made using the materials and procedures described in United States Patent Application Serial
No. 157,571, with an average diameter of about 0.5 μ. These vesicles had an oil-based center with the liposoluble red dye "Oil Red O" incorporated in the oil as a marker. Gelation in the presence of the vesicles lead to complete incorporation of the vesicles. Over two days, five centrifugal washings of the gels showed a gradual release of the dye-containing vesicles without fractionation or breakdown of the vesicles. This shows that this type of gel could be used as a sustained release vehicle, or that it can act as a protective barrier to large particles. Other paucilamellar lipid vesicles have also been encapsulated.
Example t
In this experiment, the same high lipid/carbohydrate ratio gel as used in Example 3 was used to show the effects of isotonic changes and permeability of small particles. The gel was -manufactured as described above and was hydrated with 25 ml of plain water. The gel was then soaked alternately in several changes of 0.5 ml of 1 M sucrose then water.
The shifts from the hypertonic to hypotonic medium and back caused only transient changes in gel volume at the time of the change of the medium, indicating free permeability of the gels to sucrose. Therefore, it is expected that the gels would also be permeable to molecules of approximately the same size as sucrose including many drugs. Accordingly, the gels could be used as a wound bandage which allows
passage of a drug through the gel to where it is necessary but protection against large particulate-type matter such as bacterial cells. In contrast, exposure of gels to a 20% solution of high molecular weight dextran (140,000 Mol. Wt.) causes reversible shrinking, suggesting that these molecules do not penetrate the gels and cause osmotic loss of water from the gels.
Example 5.
In this Example, a functional fatty acid, undecylenic acid, is used in place of a standard fatty acid in forming the gel of the invention. This functional fatty acid is a potent fungicide.
To make this gel, 1.0 g of undecylenic acid was uniformly blended with 1.0 g of carboxymethylcellulose and 0.036 g of the borate-stabilized aluminum acetate complex. The sample was hydrated by mixing 25 ml of water with 0.5 g of the mixture. Hydration was complete within thirty minutes, forming a soft gel. The gel slowly releases the undecylenic acid over time. A more rigid gel can be formed by using blends of the functional fatty acid with palmitic or stearic acid.
The soft gel is slightly turbid, spreads easily, and sticks to the skin. Because of this., a bandage or wound covering of the undecylenic acid gel could be applied to the skin, providing fungicidal benefits as well as protection against particulate bacteria and infection.
Example 6.
In this Example, two different metallo-organic complexes useful as cross-linking agents within the scope of the invention were made. The first, a palmitate-based aluminum metallo-organic complex (PX-L), is made by mixing 0.64 g palmitic acid (0.25 mmol) dissolved in 5 ml of ethanol with 1.4 g (10 mmol) aluminum monoacetate stabilized with boric acid in 5 ml of water. An opalescent solution resulted. This opalescent suspension can be mixed with carboxymethylcellulose (CMC), with or without cellulose fiber, to provide a cross-linking agent impregnated in the CMC. This same procedure may be used with equal molar amounts of lauric or stearic acid to form similar complexes.
To form an benzoate-based aluminum metallo-organic complex (BX-L), a more dilute solution is used. Specifically, 0.61 g of benzoic acid (0.50 mmol) was dissolved in 7.5 ml of ethanol. The benzoic acid solution was mixed with a solution containing 1.4 g (10 mmol) aluminum monoacetate stabilized with boric acid in 7.5 ml of water. Again, an opalescent suspension resulted. This cross-linking agent can also be impregnated into or derivatized with CMC or cellulose fiber.
Example 7.
In this Example, the organo-metallic cross-linking agents formed in Example 6 were used to form the sponge-like material of the invention. In
the first such test, 0.2 g of carboxymethylcellulose (CMC), 0.04 g of palmitic acid (PA), 0.2 ml of the benzoate-based aluminum metallo-organic cross-linking agent (BX-L) made in Example 6, and 50 ml of 0.15 N saline were blended. As one of the two variations of the experiment, 0.6 g of cellulose was also used.
The mixture was hydrated by thirty seconds of magnetic stirring and the still-liquid mixture was transferred to 50 ml centrifuge tubes and centrifuged at 300 X g for thirty minutes. At the end of the thirty minute centrifuge period, any free fluid was collected by filtration through a 150 μ pore size nylon mesh. Highly cohesive, firm gels form within the thirty minute centrifugation.
Retention of liquid was measured at least twenty-four hours after formation. Gel piece aliquots were cut out, weighed, and placed in a centrifuge tube insert, closed its bottom by a perforated screen supporting a piece of non-woven tea-bag paper. After centrifugation at 300 X g for thirty minutes, the amount of liquid released from the gel.was determined gravimetrically. Table 3 shows the results of this testing for the material of the invention (CMC/PA/BX-L), with or without cellulose. The same test was carried out using a similar amount of Sanwet IM1500 U.S., a polyacrylic superabsorber, as a control. All values with cellulose are corrected to non-cellulose activities in this and the following Examples.
TABLE 3
System Absorption fml/α)
CMC/Palmitate/Benzoate X-link 162 ± 10
+Cellulose 201 ± 4 Polyacrylic Superabsorber 60 ± 1
+Cellulose 70 ± 1
As can be seen from the results of Table 3, the composition of the invention, either with or without cellulose, clearly is superior to the polyacrylic superabsorbers in terms of retention of 0.15 N saline.
The identical experiment was performed using a composition of the invention which had the palmitate-based cross-linking agent (PX-L) in place of the benzoate-based cross-linking agent (BX-L) . Table 4 shows the results of this experiment, again compared to the superabsorber results.
TABLE 4
S ste Absorption (ml/α)
CMC/Palmitate/Palmitate X-link 207 s 1
•(-Cellulose 205 ± 1
Polyacrylic Superabsorber 60 ± 1
+Cellulose 70 ± 1
Example 8.
In this Example, a 20% whole blood solution was tested for absorption by a composition of the invention made with the benzoate-based cross-linking agent (BX-L) of Example 6. The composition was made by mixing 0.2 g of carboxymethylcellulose, 0.04 g of palmitic acid, 50 ml of 20% whole blood, 0.15 N saline and 1 ml of the cross-linking agent. Again, the material was tested with and without 0.6 g of cellulose. After hydration, the still-liquid mix was divided into to two 25 ml portions, these were transferred to 50 ml centrifuge tubes, and gelation was allowed to proceed under centrifugation at 300 X g (average 4800 lbs./in2) for thirty minutes. At the end of the centrifugation, any free fluid was collected by filtration though 150 μ pore size nylon mesh. Table 5 shows the results of this test. The value without the cellulose is equivalent to an absorption of 35 ml of whole blood, while the cellulose added value is even higher.
TABLE 5
System Absorption (ml/α)
CMC/Palmitate/Benzoate X-link 175 ± 1
• Cellulose 223 ± 1
Example 9.
In this Example, undecylenic acid is incorporated into a gel containing the benzoate-based
aluminum metallo-organic complex of Example 6. Approximately 0.5 ml of the cross-linking complex was combined with 0.5 ml carboxymethylcellulose and 0.5 g of undecylenic acid. The material was hydrated with 70 ml with deionized water. A high cohesive but mobile gel formed within thirty minutes. There was no release of water over a period of more than three hours and there was no separation of free undecylenic acid.
The same approach could be used to incorporate a variety of carboxyl terminal functional molecules such as prostaglandins, prostacyclins, thromboxanes and their precursors such as arachidonic acid. In addition, certain antibiotics such as oxytetracyline can be used in place of some or all of the cross-linking agents.
Other materials which could be used to replace part the fatty acid include carboxylic acids, carboxylic peptides, nonionic surfactants, and steroids such as cholesterol or hydrocortisone. Selection of proper acidic constituents can modify gel properties. The steroid can be present in the system up to at least 10% of the fatty acid without disturbing the gel. Therefore, these gels could be used as a delivery systems for a variety of molecules such as steroids.
In addition, as shown previously, lipid vesicles can be incorporated into the gels as particulate matter. Since these lipid vesicles can also be designed to carry a variety of materials
which could not otherwise be carried in the gel, a wound patch or other covering made of the gel with the vesicles dispersed therein could be used to apply drugs on a time-released basis to a selected site.
Those skilled in the art will be able to determine other modifications of the exemplary procedures and materials. Such other modifications are within the scope of the following claims.
What is claimed is:
Claims
1. A composition of matter which acts as a synthetic sponge when allowed to hydrate comprising a non-hydrated mixture of:
a carboxylic acid with a substantial ^ hydrophobic region; and
a branched complex carbohydrate;
whereby said composition can be hydrated and cross-linked simultaneously in the presence of a hydrating solution.
0 2. The composition of claim 1 further comprising a separate cross-linking agent.
3. The composition of claim 1 wherein said carboxylic acid 'comprises a fatty acid.
4. The composition of claim 3 wherein said fatty acid is selected from the group consisting of lauric acid, palmitic acid, stearic acid, oleic acid, benzoic acid, and mixtures thereof.
5. The composition of claim 1 wherein said carboxylic acid comprises a functional fatty acid.
6. The composition of claim 5 wherein said functional fatty acid is selected from the group consisting of undecylenic acid, arachidonic acid, prostaglandins, prostacyclins, thromboxanes, and their derivatives, chemical analogues, and precursors.
7. The composition of claim 1 wherein said branched complex carbohydrate is selected from the group consisting of carboxymethylcellulose, chitosan, and their derivatives and chemical analogues.
5 8. The composition of claim 1 further comprising a linear carbohydrate.
9. The composition of claim 2 wherein said cross-linking agent is a metallo-organic cross-linking agent which includes a multivalent 10 metal ion.
10. The composition of claim 9 wherein said multivalent metal ion is selected from the group consisting of aluminum ions, chromium ions, and other metal ions with a valence greater than 2.
15 11. The composition of claim 9 wherein said metallo-organic cross-linking agent comprises both said carboxylic acid and said cross-linking agent.
12. The composition of claim 2 wherein said cross-linking agent is an organic cross-linking agent
20 with an effective valence of at least 3.
13. The composition of claim 2 wherein said fatty acid is selected from the group consisting of lauric, palmitic, oleic, benzoic, and stearic acids, said branched complex carbohydrate is selected from
25 the group consisting of carboxymethylcellulose, chitosan, and mixtures thereof, and said cross-linking agent is selected from the group
consisting of aluminum acetate, aluminum borate, benzoate-based aluminum metallo-organic complex, palmitate-based aluminum metallo-organic complex, and mixtures thereof.
514. A method of absorbing aqueous or saline solution using a biodegradable synthetic sponge composition comprising the steps of:
providing said synthetic sponge composition in a substantially unhydrated form, said synthetic 0 sponge composition containing a carboxylic acid with a substantial hydrophobic region, and a branched complex carbohydrate;
contacting said solution to be absorbed with said synthetic sponge composition;
5 whereby said synthetic sponge composition hydrates to absorb said solution and cross-links into a gel substantially simultaneously.
15. The method of claim 14 wherein said composition further comprises a separate 0 cross-linking agent.
16. The method of claim 14 wherein said carboxylic acid comprises a fatty acid.
17. The method of claim 16 wherein said fatty acid is selected from the group consisting of lauric, 5 palmitic, benzoic, and stearic acids, and mixtures thereof.
18. The method of claim 14 wherein said branched complex carbohydrate is selected from the group consisting of carboxymethylcellulose, chitosan, and their derivatives and chemical analogues.
519. The method of claim 14 wherein said composition further comprises a linear carbohydrate.
20. The method of claim 15 wherein said cross-linking agent is selected from a group consisting of metallo-organic complexes containing
10 aluminum ions, chromium ions, and other metal ions with a valence of at least 3.
21. The method of claim 15 wherein said carboxylic acid and said cross-linking agent comprise the same molecule.
1522. The method of entrapping particles in a gel comprising the steps of:
providing a synthetic sponge composition in a substantially unhydrated form, said synthetic sponge composition containing a carboxylic acid with 20 a substantial hydrophobic region, and a branched complex carbohydrate;
contacting a solution containing said particles to be entrapped with said synthetic sponge composition;
25 whereby said gel is formed by the combined hydration and cross-linking of said synthetic sponge composition, thereby entrapping the particles.
23. The method of claim 22 wherein said composition further comprises a separate cross-linking agent.
24. The method of claim 22 wherein said carboxylic acid comprises a fatty acid.
25. The method of claim 22 wherein said particles to be entrapped are selected from the group consisting of cells, bacteria, and macromolecules.
26. The method of claim 22 wherein said fatty acid is selected from the group consisting of lauric, palmitic, benzoic, and stearic acids, and mixtures thereof.
27. The method of claim 22 wherein said branched complex carbohydrate is selected from the group consisting of carboxymethylcellulose, chitosan, and their derivatives and chemical analogues.
28. The method of claim 22 wherein said composition further comprises a linear carbohydrate.
29. The method of claim 23 wherein said cross-linking agent is selected from the group consisting of metallo-organic complexes containing aluminum ions, chromium ions, and other metal ions with a valence of at least 3.
30. The method of claim 22 wherein said entrapment acts as a barrier to the passage of said entrapped particles.
31. The method of claim 22 wherein said entrapped particles are released over time from said gel, whereby said gel acts as a sustained release vehicle.
532. The method of claim 23 wherein said carboxylic acid and said cross-linking agent comprise the same molecule.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/320,944 US4959341A (en) | 1989-03-09 | 1989-03-09 | Biodegradable superabsorbing sponge |
US320944 | 1989-03-09 | ||
PCT/US1990/001275 WO1990010426A1 (en) | 1989-03-09 | 1990-03-08 | Biodegradable superabsorbing sponge |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0593421A4 true EP0593421A4 (en) | 1993-04-30 |
EP0593421A1 EP0593421A1 (en) | 1994-04-27 |
Family
ID=23248525
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP90905032A Withdrawn EP0593421A1 (en) | 1989-03-09 | 1990-03-08 | Biodegradable superabsorbing sponge |
EP90904542A Expired - Lifetime EP0462178B1 (en) | 1989-03-09 | 1990-03-08 | Particulate absorbent material |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP90904542A Expired - Lifetime EP0462178B1 (en) | 1989-03-09 | 1990-03-08 | Particulate absorbent material |
Country Status (10)
Country | Link |
---|---|
US (1) | US4959341A (en) |
EP (2) | EP0593421A1 (en) |
JP (2) | JP2651952B2 (en) |
KR (1) | KR920700020A (en) |
AU (2) | AU624695B2 (en) |
BR (2) | BR9007212A (en) |
CA (2) | CA2049054A1 (en) |
DE (1) | DE69003810T2 (en) |
WO (2) | WO1990010495A1 (en) |
ZA (2) | ZA901853B (en) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5269979A (en) * | 1988-06-08 | 1993-12-14 | Fountain Pharmaceuticals, Inc. | Method for making solvent dilution microcarriers |
US5234621A (en) * | 1989-03-09 | 1993-08-10 | Micro Vesicular Systems, Inc. | Rinse-free shampoo containing cross-linked carboxymethylcellulose |
US5049395A (en) * | 1989-03-09 | 1991-09-17 | Micro Vesicular Systems, Inc. | Controlled release vehicle |
US4959341A (en) * | 1989-03-09 | 1990-09-25 | Micro Vesicular Systems, Inc. | Biodegradable superabsorbing sponge |
US5510117A (en) * | 1989-03-09 | 1996-04-23 | Micro-Pak, Inc. | Entrapment vehicle and method |
US5252340A (en) * | 1989-12-14 | 1993-10-12 | Isolyser Company, Inc. | Method of producing an absorbent composition |
US5650219A (en) * | 1991-04-10 | 1997-07-22 | Isolyser Co. Inc. | Method of disposal of hot water soluble garments and like fabrics |
US5871679A (en) * | 1991-04-10 | 1999-02-16 | Isolyser Company, Inc. | Method of producing hot water soluble garments and like fabrics |
US6048410A (en) * | 1991-04-10 | 2000-04-11 | Isolyser Company, Inc. | Method of disposal of hot water soluble garments and like fabrics |
CA2073292C (en) † | 1991-10-25 | 2004-06-29 | Xin Ning | Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof |
DE4206850C2 (en) * | 1992-03-05 | 1996-08-29 | Stockhausen Chem Fab Gmbh | Polymer compositions, preparation of polymer compositions, in particular absorption materials and their use |
DE4206857C2 (en) * | 1992-03-05 | 1996-08-29 | Stockhausen Chem Fab Gmbh | Polymer composition, absorbent material composition, their production and use |
DE4206856C2 (en) * | 1992-03-05 | 1996-08-29 | Stockhausen Chem Fab Gmbh | Polymer composition, absorbent material composition, their preparation and use |
CA2076732C (en) † | 1992-04-17 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | Modified polysaccharides having improved absorbent properties and process for the preparation thereof |
US5885907A (en) * | 1993-04-29 | 1999-03-23 | Isolyser Company, Inc. | Method of disposal of hot water soluble garments and like fabrics |
US5620786A (en) * | 1993-04-29 | 1997-04-15 | Isolyser Co. Inc. | Hot water soluble towels, sponges and gauzes |
EP0700415B1 (en) * | 1993-05-03 | 1997-08-06 | Stockhausen GmbH & Co. KG | Polymer composition, absorbent material composition, their production and their use |
DE4318094B4 (en) * | 1993-06-01 | 2004-03-04 | Stockhausen Gmbh & Co. Kg | Superabsorbents, processes for their preparation and their use |
EP0674920A1 (en) * | 1994-03-31 | 1995-10-04 | Bio-Sep Inc. | Process and apparatus for digesting solid waste |
US5661217A (en) * | 1994-08-05 | 1997-08-26 | Isolyser Company, Inc. | Method of manufacturing monolithic structures from polyvinyl alcohol |
US5470653A (en) * | 1994-08-05 | 1995-11-28 | Isolyser Company, Inc. | Disposable mop heads |
US5563179A (en) * | 1995-01-10 | 1996-10-08 | The Proctor & Gamble Company | Absorbent foams made from high internal phase emulsions useful for acquiring and distributing aqueous fluids |
EG21087A (en) * | 1995-01-10 | 2000-10-31 | Procter & Gamble | Foams made from high internal phase emulsions useful as absorbent members from catamenial pads |
US5650222A (en) * | 1995-01-10 | 1997-07-22 | The Procter & Gamble Company | Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios |
US5849805A (en) * | 1995-01-10 | 1998-12-15 | The Procter & Gamble Company | Process for making foams useful as absorbent members for catamenial pads |
US5770634A (en) * | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Foam materials for insulation, derived from high internal phase emulsions |
US5612045A (en) * | 1995-06-07 | 1997-03-18 | Kimberly-Clark Corporation | Inhibition of exoprotein in absorbent article |
US5685872A (en) * | 1995-06-07 | 1997-11-11 | Kimberly-Clark Worldwide, Inc. | Inhibition of exoprotein using amide compositions in absorbent article |
US5618554A (en) * | 1995-06-07 | 1997-04-08 | Kimberly-Clark Corporation | Inhibition of exoprotein using amine compositions in absorbent article and method thereof |
US5633291A (en) * | 1995-06-07 | 1997-05-27 | The Procter & Gamble Company | Use of foam materials derived from high internal phase emulsions for insulation |
US5550167A (en) * | 1995-08-30 | 1996-08-27 | The Procter & Gamble Company | Absorbent foams made from high internal phase emulsions useful for acquiring aqueous fluids |
US5707731A (en) * | 1996-05-09 | 1998-01-13 | Isolyser Company, Inc. | Disposable cleaning articles |
US5806668A (en) * | 1996-07-01 | 1998-09-15 | Bixby; Steven H. | Containment, collection and disposal device |
JP3378256B2 (en) * | 1996-09-11 | 2003-02-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | Modified porous starch |
US5891812A (en) * | 1996-10-11 | 1999-04-06 | Isolyser Company, Inc. | Liquid absorbable non-permeable fabrics and methods of making, using, and disposing thereof |
US5844007A (en) * | 1996-10-21 | 1998-12-01 | No Touch North America | Lustering and protecting agent for rubber, vinyl, and the like |
EP2305749B1 (en) * | 1996-12-13 | 2013-03-06 | DSG International Limited | Highly absorbent composite compositions, absorbent sheets provided with the compositions, and process for producing the same |
WO1998058686A1 (en) * | 1997-06-24 | 1998-12-30 | SCA Mölnlycke AB | Absorbent polymer material based on renewable starting materials |
US6013589A (en) * | 1998-03-13 | 2000-01-11 | The Procter & Gamble Company | Absorbent materials for distributing aqueous liquids |
US6083211A (en) * | 1998-03-13 | 2000-07-04 | The Procter & Gamble Company | High suction polymeric foam materials |
US6160028A (en) * | 1998-07-17 | 2000-12-12 | The Procter & Gamble Company | Flame retardant microporous polymeric foams |
US6245697B1 (en) | 1998-11-12 | 2001-06-12 | The Procter & Gamble Company | Flexible mat for absorbing liquids comprising polymeric foam materials |
US6794557B1 (en) | 1999-07-16 | 2004-09-21 | Associated Hygienic Products Llc | Disposable absorbent article employing an absorbent composite and method of making the same |
CA2435491C (en) * | 2001-01-31 | 2010-02-02 | Seikagaku Corporation | Crosslinked polysaccharide sponge |
DE10125599A1 (en) | 2001-05-25 | 2002-11-28 | Stockhausen Chem Fab Gmbh | Super-absorbent polymer powder for use in e.g. diapers, packaging and soil improvers, obtained by pre-swelling polycarboxy-polysaccharide in water and then drying and surface-crosslinking resulting hydrogel |
ATE432093T1 (en) * | 2002-03-14 | 2009-06-15 | Medrx Co Ltd | TOPICAL MEDICATION FOR WOUNDS |
US20040087564A1 (en) * | 2002-10-31 | 2004-05-06 | Wright D. Craig | Delivery composition and method |
EP1559315A1 (en) * | 2004-01-28 | 2005-08-03 | Stephen Marshall | Sorbent additive and composition |
US20060246186A1 (en) * | 2005-04-28 | 2006-11-02 | Nowak Michael J | Polycarboxylated polymer, method of making, method of use, and superabsorbent compositions including the same |
WO2006125167A2 (en) * | 2005-05-18 | 2006-11-23 | Eye Safety Systems, Inc. | Goggles with removable frame and methods of making and using the same |
EP2066699B1 (en) * | 2006-09-25 | 2020-02-12 | Archer-Daniels-Midland Company | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
US7785710B2 (en) | 2006-10-02 | 2010-08-31 | Weyerhaeuser Nr Company | Superabsorbent particles containing carboxyalkyl cellulose and temporary metal crosslinks |
US7625463B2 (en) | 2006-10-02 | 2009-12-01 | Weyerhaeuser Nr Company | Methods for the preparation of fibrous superabsorbent composite containing cellulose |
US20080078514A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Methods for the preparation of cellulose fibers having superabsorbent particles adhered thereto |
US7645806B2 (en) * | 2006-10-02 | 2010-01-12 | Weyerhaeuser Nr Company | Methods for the preparation of superabsorbent particles containing carboxyalkyl cellulose |
US20080079188A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Methods for the preparation of mixed polymer superabsorbent fibers |
US7717995B2 (en) * | 2006-10-02 | 2010-05-18 | Weyerhaeuser Nr Company | Methods for the preparation of mixed polymer superabsorbent fibers containing cellulose |
US20080081165A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Fibrous superabsorbent composite containing cellulose |
US20080082065A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Mixed polymer superabsorbent fibers containing cellulose |
FR2917292B1 (en) * | 2007-06-18 | 2014-06-13 | Centre Nat Rech Scient | USE OF A HEMOGLOBIN FOR THE PREPARATION OF DRESSINGS, AND DRESSINGS THUS PREPARED |
US7749317B2 (en) | 2007-06-25 | 2010-07-06 | Weyerhaeuser Nr Company | Fibrous blend and method of making |
US7591891B2 (en) * | 2007-06-25 | 2009-09-22 | Weyerhaeuser Nr Company | Fibrous blend and methods of preparation |
JP5680817B2 (en) * | 2008-03-31 | 2015-03-04 | ユニ・チャーム株式会社 | Absorber that forms crosslinks upon absorption |
US7833384B2 (en) * | 2008-06-30 | 2010-11-16 | Weyerhaeuser Nr Company | Method for making fiber having biodegradable superabsorbent particles attached thereto |
US20090325797A1 (en) * | 2008-06-30 | 2009-12-31 | Weyerhaeuser Co. | Biodegradable Superabsorbent Particles |
US7959762B2 (en) * | 2008-06-30 | 2011-06-14 | Weyerhaeuser Nr Company | Method for making biodegradable superabsorbent particles |
US20090326180A1 (en) * | 2008-06-30 | 2009-12-31 | Weyerhaeuser Co. | Biodegradable Superabsorbent Particles Containing Cellulose Fiber |
US8641869B2 (en) * | 2008-06-30 | 2014-02-04 | Weyerhaeuser Nr Company | Method for making biodegradable superabsorbent particles |
US8084391B2 (en) * | 2008-06-30 | 2011-12-27 | Weyerhaeuser Nr Company | Fibers having biodegradable superabsorbent particles attached thereto |
US8101543B2 (en) * | 2008-06-30 | 2012-01-24 | Weyerhaeuser Nr Company | Biodegradable superabsorbent particles |
US9107975B2 (en) | 2009-02-20 | 2015-08-18 | Archer Daniels Midland Co. | Acidic gases permeated carboxyalkyl starch and alkaline starch extrudates and process for making the same |
GB2492171A (en) * | 2011-06-24 | 2012-12-26 | Sca Hygiene Prod Ab | Sanitary articles comprising biodegradable plastic and Bacillus spores |
CN103240065B (en) * | 2013-05-03 | 2015-06-03 | 大连理工大学 | Elastic hydrophobic material and synthetic method as well as application thereof |
US20180021477A1 (en) * | 2015-02-27 | 2018-01-25 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Medical material and anti-adhesion material |
CN107249657A (en) * | 2015-02-27 | 2017-10-13 | 大日精化工业株式会社 | Manufacture method, medical material and the adherence preventing material of medical material |
JP6374089B2 (en) * | 2015-02-27 | 2018-08-15 | 大日精化工業株式会社 | Medical / beauty materials and anti-adhesion materials |
US20210290452A1 (en) * | 2020-03-20 | 2021-09-23 | Tethis, Inc. | Systems and methods for treating an article including a biodegradable superabsorbent material |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3741894A (en) * | 1967-06-15 | 1973-06-26 | Exxon Production Research Co | Chemically modified organic polymers |
EP0009977A1 (en) * | 1978-10-05 | 1980-04-16 | Unilever Plc | A water-swellable particulate absorbent material and method for producing this material |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160063A (en) * | 1973-11-16 | 1979-07-03 | Shell Oil Company | Method for preventing the adherence of oil to surfaces |
US4090013A (en) * | 1975-03-07 | 1978-05-16 | National Starch And Chemical Corp. | Absorbent composition of matter |
GB1453279A (en) * | 1975-03-07 | 1976-10-20 | Johnson & Son Inc S C | Solid air freshener gels |
SU779473A1 (en) * | 1978-12-21 | 1980-11-15 | Центральный научно-исследовательский институт бумаги | Paper pulp production method |
CA1152483A (en) * | 1979-04-23 | 1983-08-23 | John H.C. Windust | Absorbent materials |
JPS56155203A (en) * | 1980-04-30 | 1981-12-01 | Kuraray Co Ltd | Production of carboxyl group-containing polymer material |
US4454055A (en) * | 1980-08-25 | 1984-06-12 | National Starch And Chemical Corporation | Absorbent composition of matter, process for preparing same and article prepared therefrom |
US4486335A (en) * | 1982-08-30 | 1984-12-04 | Hercules Incorporated | Carboxymethyl hydroxyethyl cellulose composition |
US4610678A (en) * | 1983-06-24 | 1986-09-09 | Weisman Paul T | High-density absorbent structures |
US4548847A (en) * | 1984-01-09 | 1985-10-22 | Kimberly-Clark Corporation | Delayed-swelling absorbent systems |
JPS60226832A (en) * | 1984-04-02 | 1985-11-12 | Daicel Chem Ind Ltd | Separating agent containing polysaccharide fatty acid ester |
JPS63152667A (en) * | 1986-08-22 | 1988-06-25 | Kao Corp | Water-absorptive resin with high stability |
DE8712723U1 (en) * | 1986-12-08 | 1987-12-17 | Hanfspinnerei Steen & Co Gmbh, 2000 Hamburg, De | |
US4826880B1 (en) * | 1987-09-21 | 2000-04-25 | Johnson & Johnson Inc | Immobilizing particulate absorbents by conversion to hydrates |
FR2620914B1 (en) * | 1987-09-25 | 1991-11-08 | Oreal | SHEET MATERIAL FOR PERFORMING SKIN OR HAIR TREATMENT, METHOD FOR MANUFACTURING SAME, AND ARTICLES MADE THEREOF |
US4952550A (en) * | 1989-03-09 | 1990-08-28 | Micro Vesicular Systems, Inc. | Particulate absorbent material |
US4959341A (en) * | 1989-03-09 | 1990-09-25 | Micro Vesicular Systems, Inc. | Biodegradable superabsorbing sponge |
US4944734A (en) * | 1989-03-09 | 1990-07-31 | Micro Vesicular Systems, Inc. | Biodegradable incontinence device with embedded granules |
-
1989
- 1989-03-09 US US07/320,944 patent/US4959341A/en not_active Expired - Lifetime
-
1990
- 1990-03-08 BR BR909007212A patent/BR9007212A/en not_active Application Discontinuation
- 1990-03-08 WO PCT/US1990/001049 patent/WO1990010495A1/en active IP Right Grant
- 1990-03-08 AU AU52676/90A patent/AU624695B2/en not_active Ceased
- 1990-03-08 DE DE90904542T patent/DE69003810T2/en not_active Expired - Fee Related
- 1990-03-08 BR BR909007210A patent/BR9007210A/en not_active Application Discontinuation
- 1990-03-08 WO PCT/US1990/001275 patent/WO1990010426A1/en not_active Application Discontinuation
- 1990-03-08 AU AU52841/90A patent/AU627014B2/en not_active Ceased
- 1990-03-08 JP JP2505069A patent/JP2651952B2/en not_active Expired - Lifetime
- 1990-03-08 KR KR1019900702416A patent/KR920700020A/en not_active Application Discontinuation
- 1990-03-08 CA CA002049054A patent/CA2049054A1/en not_active Abandoned
- 1990-03-08 JP JP2504607A patent/JPH0720547B2/en not_active Expired - Lifetime
- 1990-03-08 CA CA002049055A patent/CA2049055C/en not_active Expired - Fee Related
- 1990-03-08 EP EP90905032A patent/EP0593421A1/en not_active Withdrawn
- 1990-03-08 EP EP90904542A patent/EP0462178B1/en not_active Expired - Lifetime
- 1990-03-09 ZA ZA901853A patent/ZA901853B/en unknown
- 1990-03-13 ZA ZA901923A patent/ZA901923B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3741894A (en) * | 1967-06-15 | 1973-06-26 | Exxon Production Research Co | Chemically modified organic polymers |
EP0009977A1 (en) * | 1978-10-05 | 1980-04-16 | Unilever Plc | A water-swellable particulate absorbent material and method for producing this material |
Non-Patent Citations (2)
Title |
---|
DATABASE WPIL, accession no. 82-00826E (01), Derwent Publications Ltd, London, GB; & JP-A-56 155 203 (KURARAY K.K.) 01-12-1981 * |
See also references of WO9010426A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE69003810D1 (en) | 1993-11-11 |
WO1990010426A1 (en) | 1990-09-20 |
DE69003810T2 (en) | 1994-05-05 |
CA2049055A1 (en) | 1990-09-10 |
EP0462178A1 (en) | 1991-12-27 |
KR920700020A (en) | 1992-02-19 |
WO1990010495A1 (en) | 1990-09-20 |
AU5284190A (en) | 1990-10-09 |
AU5267690A (en) | 1990-10-09 |
EP0462178B1 (en) | 1993-10-06 |
ZA901923B (en) | 1991-05-29 |
BR9007212A (en) | 1992-03-24 |
AU624695B2 (en) | 1992-06-18 |
ZA901853B (en) | 1991-08-28 |
JP2651952B2 (en) | 1997-09-10 |
EP0593421A1 (en) | 1994-04-27 |
JPH04504978A (en) | 1992-09-03 |
JPH04504969A (en) | 1992-09-03 |
US4959341A (en) | 1990-09-25 |
BR9007210A (en) | 1992-02-18 |
CA2049054A1 (en) | 1990-09-10 |
JPH0720547B2 (en) | 1995-03-08 |
EP0462178A4 (en) | 1992-06-03 |
AU627014B2 (en) | 1992-08-13 |
CA2049055C (en) | 1994-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4959341A (en) | Biodegradable superabsorbing sponge | |
US5073202A (en) | Method of using a biodegradable superabsorbing sponge | |
KR100432233B1 (en) | Layered body for absorbing liquids, its production and use | |
EP0019371B1 (en) | Absorbent materials, process for making them and their use in immobilising blood | |
US4624868A (en) | Borated polysaccharide absorbents and absorbent products | |
CA1158220A (en) | Borated polysaccharide absorbents and absorbent products | |
US5977428A (en) | Absorbent hydrogel particles and use thereof in wound dressings | |
US6376011B1 (en) | Process for preparing superabsorbent-containing composites | |
JP4902887B2 (en) | Antibacterial wound contact layer | |
US5064653A (en) | Hydrophilic foam compositions | |
US5065752A (en) | Hydrophilic foam compositions | |
EP1588723B1 (en) | Absorbent member for absorbent articles comprising swellable polymers of high permeability which are capable of forming hydrogels | |
CN100441236C (en) | Superabsorbent polymer | |
AU2003208303B2 (en) | A wound care device | |
AU713072B2 (en) | A method of producing an absorbent material, an absorbent material and absorbent articles including the material in question | |
JPH01230671A (en) | Absorbing hydride and immobilization thereof | |
CZ289319B6 (en) | Polymer system, particularly absorption system, process of its preparation and use | |
GB1570485A (en) | Absorbent material for aqueous fluids | |
CA2486057A1 (en) | Hydrophilic foam compositions having antimicrobial properties | |
US5234915A (en) | Biodegradable gel | |
EP4338762A1 (en) | Process of producing a highly absorbent hydrogel composition for medical purposes, in particular for wound treatment | |
CN109010898A (en) | A kind of chitosan-based gauze dressing of loaded metal ion and preparation method thereof | |
EP0084190A2 (en) | Medicinal composition, package and method of making the composition | |
EP0930898B1 (en) | Wound dressings | |
Mutya et al. | Evaluation of the sorption properties of a self-adhesive hydrogel wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19910923 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19951002 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19961224 |